Access, cost & regulation

Generic drug

Also called: generic

By GLP Index editorial Updated July 17, 2026

A generic drug is a copy of a brand-name medication with the same active ingredient, strength, and intended use, approved once the brand's patents and exclusivity expire — and usually much cheaper. Importantly, there is no generic Ozempic, Wegovy, or Zepbound yet: these are still under exclusivity, so any "generic GLP-1" you see advertised is compounded, not FDA-approved.

What a generic drug is

A generic drug is a copy of a brand-name medication that contains the same active ingredient, in the same strength and dosage form, for the same use. Generics go through FDA review to show they work the same way in the body, and they typically arrive — at a much lower price — once the brand’s patents and market exclusivity expire. The lower cost comes from not repeating the original’s full development, plus competition among makers.

The “generic Ozempic” question

This is where GLP-1s trip people up, so it’s worth being blunt: there is no generic Ozempic, Wegovy, Mounjaro, or Zepbound. Semaglutide and tirzepatide are still under patent and exclusivity, so no FDA-approved generic exists yet. Anything advertised as “generic Ozempic” or a cheap generic GLP-1 is almost always compounded semaglutide from a compounding pharmacy — a different regulatory category that is not an FDA-approved generic.

When might generics arrive

There’s no confirmed public date. It depends on when the relevant patents and exclusivity lapse and whether manufacturers earn approval — and because these are complex injectable peptides, the path can look different from ordinary tablets, sitting closer to the biosimilar conversation than to a simple pill copy. Treat any specific “generic coming soon” date you see as marketing rather than fact, and check real coverage through an insurance coverage check instead.

Learn more

Frequently asked

Is there a generic version of Ozempic or Wegovy?
No. As of now there's no FDA-approved generic for semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound); they remain under patent and regulatory exclusivity. Products marketed as "generic Ozempic" are typically compounded semaglutide, which is not an FDA-approved generic and is a different regulatory category.
When will generic GLP-1s be available?
There's no confirmed public date, and it depends on when patents and exclusivity lapse and whether manufacturers win approval. Because these are complex injectable peptides, the path may differ from ordinary pills. It's safest to treat any specific "coming soon" date you see as marketing rather than fact.

Sources

Every claim on this page traces to primary literature or FDA labeling — browse the full evidence library.

  1. GLP-1 agonists — Cleveland Clinic
  2. MedlinePlus — U.S. National Library of Medicine
This page is for informational purposes only and isn't medical advice. Talk to a licensed healthcare provider about your situation before starting, stopping, or changing any medication. See our medical disclaimer and editorial policy.

Written by the GLP Index editorial team · Updated July 17, 2026 · How we source

Find the right GLP‑1 in 2 minutes

Free · No account · Independent